"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
Descriptor ID |
D011471
|
MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 1 | 8 |
1995 | 6 | 3 | 9 |
1996 | 13 | 2 | 15 |
1997 | 9 | 0 | 9 |
1998 | 12 | 2 | 14 |
1999 | 11 | 2 | 13 |
2000 | 9 | 0 | 9 |
2001 | 12 | 2 | 14 |
2002 | 14 | 5 | 19 |
2003 | 16 | 3 | 19 |
2004 | 24 | 6 | 30 |
2005 | 25 | 1 | 26 |
2006 | 26 | 5 | 31 |
2007 | 46 | 3 | 49 |
2008 | 34 | 5 | 39 |
2009 | 43 | 9 | 52 |
2010 | 44 | 1 | 45 |
2011 | 45 | 1 | 46 |
2012 | 49 | 4 | 53 |
2013 | 38 | 4 | 42 |
2014 | 58 | 4 | 62 |
2015 | 56 | 7 | 63 |
2016 | 53 | 5 | 58 |
2017 | 60 | 9 | 69 |
2018 | 52 | 5 | 57 |
2019 | 60 | 4 | 64 |
2020 | 56 | 6 | 62 |
2021 | 52 | 1 | 53 |
2022 | 41 | 1 | 42 |
2023 | 34 | 0 | 34 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance). Pharmacogenomics J. 2024 Mar 04; 24(2):6.
-
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons. Cold Spring Harb Mol Case Stud. 2023 Dec; 9(4).
-
Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen. Am J Clin Pathol. 2024 Jan 04; 161(1):1-3.
-
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. Ann Fam Med. 2024 Jan-Feb; 22(1):5-11.
-
A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest. BMC Med Imaging. 2023 12 08; 23(1):205.
-
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis. Clin Cancer Res. 2023 Dec 01; 29(23):4930-4940.
-
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness. Prostate. 2024 Feb; 84(3):292-302.
-
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer. Urology. 2024 Feb; 184:135-141.
-
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 11 08; 115(11):1364-1373.
-
Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):146-153.